DC20987 |
Cedazuridine
Featured
|
Cedazuridine (E7727) is a novel cytidine deaminase inhibitor, and a componet of ASTX727 for treatment of hematologic malignancies.. |
|
DCAPI1386 |
Cefdinir (Omnicef) |
Cefdinir (Omnicef) |
|
DC8686 |
Cefetamet pivoxil hydrochloride |
Cefetamet pivoxil hydrochloride is an oral third generation cephalosporin antibiotic. |
|
DC9358 |
Cefmenoxime (hydrochloride) |
Cefmenoxime hydrochloride is a third-generation cephalosporin antibiotic. |
|
DCAPI1038 |
Cefoselis sulfate |
Cefoselis sulfate |
|
DC20190 |
Cefoxitin |
Cefoxitin is a beta-lactam, second-generation cephalosporin antibiotic with bactericidal activity. |
|
DC8067 |
Cefozopran
Featured
|
Cefozopran (SCE-2787) is a new parenteral cephalosporin, against experimental infections in mice. |
|
DC9356 |
Cefpiramide (sodium) |
Cefpiramide sodium (SM-1652; Wy-44635) is a new Pseudomonas-active cephalosporin with a broad spectrum of antibacterial activity.
|
|
DC8687 |
Cefpirome sulfate |
Cefpirome Sulfate is a fourth generation cephalosporin antibiotic. |
|
DCAPI1033 |
Cefprozil hydrate (Cefzil) |
Cefprozil hydrate (Cefzil) |
|
DC9355 |
Ceftibuten (dihydrate) |
Ceftibuten dihydrate is a third-generation cephalosporin antibiotic. |
|
DC12245 |
Ceftizoxime |
Ceftizoxime is a bacterial inhibitor which acts by interfering with bacterial cell wall synthesis and inhibiting cross-linking of the peptidoglycan. |
|
DC7569 |
Z-LEHD-FMK |
Cell permeable fluoromethyl ketone (FMK)-derivatized peptides act as effective irreversible Caspase inhibitors with no cytotoxic effects and, therefore, are useful tools for studying Caspase activity. |
|
DC23359 |
CeMMEC2 |
CeMMEC2 is a novel potent BRD4 inhibitor with IC50 of 0.9 uM, binds to both bromodomains of BRD4, comparably to (S)-JQ1.. |
|
DC10316 |
Cenicriviroc
Featured
|
Cenicriviroc is an orally active, dual CCR2/CCR5 antagonist, and displays potent anti-inflammatory and aninfective activity. |
|
DC21554 |
AS 703569 |
Cenisertib (AS 703569;R763) is a novel potent, orally available inhibitor of Aurora kinases, exhibits signifficant anti-proliferative activity against a wide range of tumor cells both in vitro and in vivo (A549 EC50=9 nM). |
|
DC12318 |
Centanafadine hydrochloride (EB-1020 (hydrochloride)) |
Centanafadine (hydrochloride) is dual norepinephrine (NE)/dopamine (DA) transporter inhibitor, also inhibits serotonin transporter, with IC50s of 6 nM, 38 nM and 83 nM for human NE, DA and serotonin transporter , respectively. |
|
DC12319 |
Centanafadine (EB-1020) |
Centanafadine is dual norepinephrine (NE)/dopamine (DA) transporter inhibitor, also inhibits serotonin transporter, with IC50s of 6 nM, 38 nM and 83 nM for human NE, DA and serotonin transporter , respectively. |
|
DC22796 |
CEP-1347 |
CEP-1347 (KT-7515) is a potent and selective MLK inhibitor that completely rescues motoneurons and inhibits JNK1 activation with IC50 of 20 nM. |
|
DC23856 |
CEP-7055 |
CEP-7055 is a potent, orally active, pan inhibitor of VEGFR, CEP-7055 is the dimethylglycine ester prodrug of CEP-5214, which inhibits human VEGFR2/KDR kinase, VEGFR1/FLT-1 kinase, and VEGFR3/FLT-4 kinase with IC50 of 18 nM, 12 nM, and 17 nM. |
|
DC7347 |
Cephalosporin C Na salt
Featured
|
Cephalosporin C Na salt is used to study the effect of transpeptidase expression, binding, and inhibition on bacterial cell wall mucopeptide synthesis. |
|
DC7346 |
Cephalosporin C zinc salt
Featured
|
Cephalosporin C zinc salt is used to study the effect of transpeptidase expression, binding, and inhibition on bacterial cell wall mucopeptide synthesis. |
|
DC9649 |
Cephalotaxlen
Featured
|
Cephalotaxine is an antiviral as well as antitumor agent. |
|
DC10226 |
Cefradine |
Cephradine is a semi-synthetic cephalosporin antibiotic. |
|
DC9500 |
Cevimeline (hydrochloride hemihydrate)
Featured
|
Cevimeline hydrochloride hemihydrate, a novel muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren's syndrome. |
|
DC7899 |
Cevipabulin(TTI 237) |
Cevipabulin, also known as TTI-237, an antimicrotubule agent, is a small synthetic molecule of triazolopyrimidine derivative with potential antitumor activity. |
|
DC22052 |
CFI02 |
CFI02 (CFI-02) is a specific inhibitor of human cytomegalovirus (HCMV) glycoprotein B-mediated fusion with IC50 of 40 nM against laboratory adapted HCMV strain AD169. |
|
DC10069 |
CFI-400437
Featured
|
CFI-400437 is potent against PLK4 (IC50 = 0.6 nM) and selective against other members of the PLK family (>10 uM). |
|
DC23338 |
CFI-401980 |
CFI-401980 is a potent, selective, novel class TTK (Tyrosine Threonine Kinase) inhibitor with Ki of 0.8 nM, HCT116 GI50 of 13 nM. |
|
DC11133 |
CFM-4.16 |
CFM-4.16 is a CARP-1 functional mimetic (CFM) compound bind with CARP-1, stimulates CARP-1 expression and apoptosis. |
|